IT Brief Ireland - Technology news for CIOs & IT decision-makers
Ireland
Dexcom opens €300 million Athenry plant, adding 500 jobs

Dexcom opens €300 million Athenry plant, adding 500 jobs

Thu, 19th Nov 2026 (Today)
Sofiah Nichole Salivio
SOFIAH NICHOLE SALIVIO News Editor

Dexcom has opened a €300 million manufacturing facility in Athenry, County Galway, its first manufacturing operation in Europe, the Middle East and Africa.

Commercial production is already under way, with the first continuous glucose monitoring sensors coming off the line after manufacturing began in October. The opening marks the site's transition from construction to commercial manufacturing and adds a new base to Dexcom's global production network.

Dexcom has hired almost 500 people for the facility so far, most of them from the West of Ireland. The company has previously said the Athenry site would create more than 1,000 jobs, with the remaining roles expected to be filled as output rises in the coming years.

Senior Irish ministers and Dexcom executives attended the opening, underlining the significance of the investment for the country's medical technology industry. The project is backed by the Irish Government through IDA Ireland.

Ireland already has a substantial medtech base in the west of the country. Dexcom said the regional cluster across Galway, Mayo and Roscommon employs 16,000 people, and the arrival of another international manufacturer adds to that concentration.

The Athenry investment was first announced when Dexcom broke ground on the site in January 2024. At the time, it said it planned to invest about €300 million over five years in the facility, which now serves as its first manufacturing presence in the EMEA region.

Regional jobs

The workforce build-out is one of the project's most immediate local effects. Almost 500 jobs have already been created, and recruitment is set to continue across a range of disciplines as production expands.

For Ireland, the project brings another high-value manufacturing employer outside Dublin and reinforces Galway's standing as a centre for medical devices. The scale of the investment is also notable at a time when governments across Europe are trying to attract long-term industrial projects with export potential.

Speaking at the opening, An Taoiseach Micheál Martin linked the project to employment and regional development. "The official opening of Dexcom's Athenry facility is a tremendous vote of confidence in the people and talent of the West of Ireland. It is particularly encouraging to see almost 500 people already part of the team, building careers in a world-leading industry and contributing to technologies that make a real difference to people's lives. These are the kinds of high-quality employment opportunities that strengthen communities, attract further investment and help ensure that Galway and the wider region continue to thrive. The opening of this facility is an important milestone, not only for Dexcom, but for Athenry and Ireland's continued success as a global centre for medical technology," Martin said.

Manufacturing network

For Dexcom, the new Irish plant extends its production footprint beyond the US and Asia Pacific. The company makes continuous glucose monitoring systems used by people with diabetes to track glucose levels, and the Athenry facility is expected to support demand in Europe, the Middle East, Africa and other markets.

Jake Leach, President and Chief Executive Officer of Dexcom, said the plant was part of a broader expansion of the company's manufacturing base. "The opening of Athenry is an important milestone for Dexcom, establishing our first manufacturing presence in EMEA and reinforcing our long-term commitment to Ireland. As we bring Dexcom CGM to more people around the world, expanding our manufacturing capabilities is fundamental to supporting the continued growth of our business. With large-scale manufacturing facilities now operating across the U.S., Europe, and Asia Pacific, we are well positioned to support our ambitious growth plans, and Athenry will play a critical role in the next chapter of Dexcom's global story," Leach said.

The opening also carried symbolic importance for the company and the wider diabetes community. Dexcom said the event was timed for the week after World Diabetes Day, with representatives from Diabetes Ireland, International Diabetes Federation Europe and Thriveabetes attending.

Columba McGarvey, Senior Vice President of Global Manufacturing Operations at Dexcom, highlighted the workforce behind the site's launch into commercial production. "What makes Dexcom Athenry special is its people. We have already assembled a remarkable team of almost 500 people, the vast majority from right here in the West of Ireland, and together they are now making CGM sensors that can help transform how millions of people worldwide manage their health. Behind every sensor we make is a person living with diabetes, and the knowledge that our work can help make their lives easier, healthier and more fulfilling is what makes our team's contribution so meaningful," McGarvey said.